Enfusion

Enfusion Buyback Yield

Delisted

Buyback Yield of Enfusion (ENFN) as of Nov 7, 2026.

Buyback Yield

0.00

Last updated:

Buyback Yield of Enfusion is 2024 0.00 . Buyback Yield of Enfusion was 2023 4.33 % . It decreases by % lower compared to the previous year.

The Enfusion Buyback Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Buyback Yield
Date
Buyback Yield
Jan 1, 2019
4.11 USD
Jan 1, 2020
5.48 USD
Jan 1, 2021
6.29 USD
Jan 1, 2022
0.57 USD
Jan 1, 2023
4.33 USD
Jan 1, 2024
0.00 USD
The Enfusion Buyback Yield history
YEARBuyback YieldYoY
0.00-100.00%
4.33 %+659.48%
0.57 %-90.94%
6.29 %+14.63%
5.48 %+33.39%
4.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

On Eulerpool you can find the complete historical development of Buyback Yield Enfusion since 2006 – with annual values, charts, and detailed analysis.

Buyback yield measures the percentage of market cap returned to shareholders through share repurchases. It complements dividend yield in assessing total shareholder returns.

To evaluate Buyback Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Buyback Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Buyback Yield's Enfusion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Enfusion

All Key Metrics — Enfusion